文献速递外周动脉疾病主动脉疾病颈动脉与弓上血管

执业血管外科医生的危险因素管理行为调查

Risk Factor Modification Behaviors of Practicing Vascular Surgeons.
PubMed 文献 · Ann Vasc Surg · 2017-05-29

本研究向血管与腔内血管外科协会633名会员发放匿名电子问卷,调查血管外科医生在戒烟和危险因素管理方面的参与情况,并分析执业变量是否影响服务提供。149名(24%)医生完成调查,虽多数会询问吸烟状态、评估戒烟意愿并建议戒烟,但仅少数处方药物、进行戒烟随访或验证戒烟。学术与私立医院医生戒烟技术无差异,但学术医生更少为持续吸烟的跛行患者行腔内手术,更常处方初始降脂药。

要点

  • 多数血管外科医生询问吸烟状态、评估戒烟意愿并建议戒烟,但仅少数处方药物或随访验证。
  • 仅26%受访者认为自己在危险因素管理方面受过良好培训。
  • 学术医生较私立医生更少为持续吸烟的跛行患者行腔内手术(29% vs. 46%,P=0.03)。

核心结论

  • 烟草依赖仍是血管外科患者的关键问题,但戒烟技术使用差异大。
  • 多数血管外科医生不精通戒烟技术和危险因素管理,应在培训中加强教育。

研究设计与样本

  • 匿名电子问卷发送给血管与腔内血管外科协会会员(n=633)。
  • 评估培训后时间、执业类型(学术与非学术)、医院规模、地区和工作量的影响,采用单因素列联表分析。

主要发现

  • 149名(24%)完成调查;97%询问吸烟状态,84%评估戒烟意愿,95%建议戒烟。
  • 仅34%处方戒烟药物,7%进行戒烟随访,3%用可替宁或一氧化碳监测验证戒烟。
  • 处方戒烟药物的医生更可能评估戒烟意愿、处方/建议尼古丁替代或处方初始他汀/其他降脂药。
  • 仅26%受访者认为培训中危险因素管理教育良好;学术与私立医生戒烟技术无差异。
  • 学术医生更少为持续吸烟的跛行患者行腔内手术(29% vs. 46%,P=0.03),更常处方初始降脂药(65% vs. 39%,P=0.0018)。

临床怎么用

  • 血管外科医生应加强戒烟药物处方、随访和戒烟验证的临床实践。
  • 培训项目应加强危险因素管理教育,提升医生戒烟技术能力。
  • 对持续吸烟的跛行患者,学术医生更谨慎选择腔内手术,此差异值得关注。

局限性

  • 调查回复率仅24%,可能存在无应答偏倚。
  • 采用单因素分析,未多因素调整混杂因素。
  • 样本来自单一学会会员,代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: National smoking rates have declined; however, it remains the primary modifiable risk factor for nearly all vascular disease. While vascular surgeons have the availability to treat patients via medical or surgical/endovascular means, involvement in risk factor modification may be lacking. This study seeks to understand vascular surgeons' involvement in tobacco cessation and risk factor modification and to determine if practice variables had any effect on provision of these services to vascular surgery patients. METHODS: Anonymous electronic surveys examining tobacco cessation and risk factor modification were sent to the Vascular & Endovascular Surgery Society members (n = 633). Influence of time from training, practice type (dichotomized into academic and nonacademic vascular surgeons), hospital size, region, and workload was assessed, and data were analyzed by univariate contingency tables. RESULTS: A total of 149 (24%) surveys were completed. While the majority of respondents ask patient's smoking status (97%), assess willingness to quit (84%), and advise patients to quit (95%), only 34% prescribe medications to assist in cessation, 7% see patients in tobacco cessation follow-up, and 3% verify cessation with cotinine levels or carbon monoxide monitoring. Surgeons who prescribed medications for cessation are more likely to assess patient's willingness to quit, prescribe/advise nicotine replacement, or prescribe initial statin or other lipid-lowering medications. There was no difference in perceived education received during training in risk factor modification, but only 26% of respondents thought they were well trained. Comparing academic to private practice vascular surgeons, there was no difference in cessation techniques used; however, academic surgeons were less likely to perform endovascular procedures for claudication in patients who continued to smoke (29% vs. 46%, P = 0.03) and more likely to prescribe an initial antihyperlipid medication (65% vs. 39%, P = 0.0018). CONCLUSIONS: Tobacco dependence remains a critical issue for vascular surgery patients; however, there is wide variation in cessation techniques used. The majority of vascular surgeons are not well versed in cessation techniques and risk factor modification, and thus, efforts should be made to provide this education in vascular surgery training programs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bader AP, Barone CP, Smeds MR, et al. Risk Factor Modification Behaviors of Practicing Vascular Surgeons. Ann Vasc Surg. 2017. PMID: 28572029. doi:10.1016/j.avsg.2017.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。